Cargando…

Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma

Objectives: LncRNAs are essential survival prognostic indicators with important biological functions in tumorigenesis and tumor progression. This study aimed to establish a long non-coding RNA (lncRNA) signature that can effectively predict the prognosis of patients with head and neck squamous cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Bowen, Shen, Jiming, Xu, Lu, Chen, Ying, Che, Xiaofang, Qu, Xiujuan, Liu, Yunpeng, Teng, Yuee, Li, Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759597/ https://www.ncbi.nlm.nih.gov/pubmed/31620361 http://dx.doi.org/10.3389/fonc.2019.00898

Ejemplares similares

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021)

An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma
por: Chen, Yue, et al.
Publicado: (2021)

A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma
por: Liu, Guancheng, et al.
Publicado: (2018)

Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma
por: Wang, Jian, et al.
Publicado: (2021)

Development and Validation of an Autophagy-Related LncRNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Shen, Lin, et al.
Publicado: (2021)

Identification of a Hypoxia-Related lncRNA Biomarker Signature for Head and Neck Squamous Cell Carcinoma
por: Yang, Cuifang, et al.
Publicado: (2022)

Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma
por: Yin, Ji, et al.
Publicado: (2021)

A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC)
por: Wang, Peng, et al.
Publicado: (2018)

Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma
por: Ji, Yanping, et al.
Publicado: (2020)

Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma
por: Zhang, Jinfeng, et al.
Publicado: (2022)

Immune-related lncRNA classification of head and neck squamous cell carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2022)

Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2019)

The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
por: Li, Yao jun, et al.
Publicado: (2022)

Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma
por: He, Xiaohua, et al.
Publicado: (2022)

Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas
por: Kolenda, Tomasz, et al.
Publicado: (2019)

Identification of lncRNA Signature of Tumor-Infiltrating T Lymphocytes With Potential Implications for Prognosis and Chemotherapy of Head and Neck Squamous Cell Carcinoma
por: Wang, Liping, et al.
Publicado: (2022)

Construction of a necroptosis‐related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma
por: Meng, Zilu, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer
por: Liu, Xiajing, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma
por: Ren, He, et al.
Publicado: (2020)

Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for head and neck squamous cell carcinoma
por: Mao, Rui, et al.
Publicado: (2020)

Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Sun, Qi, et al.
Publicado: (2021)

LncRNA PVT1 promotes malignant progression in squamous cell carcinoma of the head and neck
por: Yu, Changyun, et al.
Publicado: (2018)

Clusterization in head and neck squamous carcinomas based on lncRNA expression: molecular and clinical correlates
por: de Lena, Pelayo G., et al.
Publicado: (2017)

The Role of lncRNA Crosstalk in Leading Cancer Metastasis of Head and Neck Squamous Cell Carcinoma
por: Wang, Yu, et al.
Publicado: (2020)

Construction of an m6A‐related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma
por: Gong, Zhenyu, et al.
Publicado: (2020)

Immune‐related eight‐lncRNA signature for improving prognosis prediction of lung adenocarcinoma
por: Chen, Yan, et al.
Publicado: (2021)

Liquid lncRNA Biopsy for the Evaluation of Locally Advanced and Metastatic Squamous Cell Carcinomas of the Head and Neck
por: Łasińska, Izabela, et al.
Publicado: (2020)

The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define
por: Kozłowska, Joanna, et al.
Publicado: (2020)

Identification of Ferroptosis-Related lncRNA Pairs for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma
por: Wu, Congxiao, et al.
Publicado: (2022)

A hypoxia‐related lncRNA model for prediction of head and neck squamous cell carcinoma prognosis
por: Xiang, Junwei, et al.
Publicado: (2022)

The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases
por: Yang, Haixiu, et al.
Publicado: (2017)

Hypoxia-Regulated lncRNA USP2-AS1 Drives Head and Neck Squamous Cell Carcinoma Progression
por: Tang, Jianmin, et al.
Publicado: (2022)

LncRNA AL161431.1 predicts prognosis and drug response in head and neck squamous cell carcinoma
por: Zhou, Mingzhu, et al.
Publicado: (2023)

Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation
por: Shi, Yu, et al.
Publicado: (2020)

Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma
por: Guan, Guo-fang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fa86hh41607c4eapdb002lm9bn